Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.32 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17351928 | 0.93 | TSHR (0.52) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL27705619 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL27705519 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL7325532 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL27726084 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL24459668 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL6249621 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL27705506 | 0.91 | ANPEP (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL20592385 | 0.90 | TSHR (0.50) | TSHRALDH1A1PKMANPEPERAP2 | |
| SCHEMBL11765569 | 0.90 | PKM (0.50) | TSHRALDH1A1PKMANPEPERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105481744-A | CO2/N2-H2O2 dual-stimulation response surfactant and preparation method thereof | UNIV JIANGNAN | 2016-04-13 | — | — | CN | claimed |
| US-20150367277-A1 | Alkanolamine-Based Carbon Dioxide Absorbent Containing Polyalkylene Glycol Monomethyl Ether, and Carbon Dioxide Absorption Method and Separation Method Using Same | UNIVERSITY-INDUSTRY COOPERATION FOUNDATION OF KYUNG HEE UNIVERSITY (KR) | 2015-12-24 | — | — | US | claimed |
| CN-111971269-B | Reaction of glycolaldehyde | 塔明克私人有限公司 | 2024-02-13 | — | — | CN | disclosed |
| US-11851390-B2 | Reaction of glycoladehyde | TAMINCO BVBA | 2023-12-26 | — | — | US | disclosed |
| US-20210139410-A1 | REACTION OF GLYCOLADEHYDE | TAMINCO BVBA (BE) | 2021-05-13 | — | — | US | disclosed |
| EP-3774717-A1 | REACTION OF GLYCOLALDEHYDE | TAMINCO BVBA (BE) | 2021-02-17 | — | — | EP | disclosed |
| CN-111971269-A | Reaction of glycolaldehyde | 塔明克公司 | 2020-11-20 | — | — | CN | disclosed |
| EP-3290401-B1 | N-SUBSTITUTED ACYCLIC ETHYLENE DIAMINES | TAMINCO BVBA (BE) | 2020-09-23 | — | — | EP | disclosed |
| WO-2019193117-A1 | REACTION OF GLYCOLALDEHYDE | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2019-10-10 | — | — | WO | disclosed |
| EP-3290401-A1 | N-SUBSTITUTED ACYCLIC ETHYLENE DIAMINES | Taminco bvba (BE) | 2018-03-07 | — | — | EP | disclosed |
| CN-105481744-A | CO2/N2-H2O2 dual-stimulation response surfactant and preparation method thereof | UNIV JIANGNAN | 2016-04-13 | — | — | CN | disclosed |
| EP-2000489-B1 | CURABLE AQUEOUS COMPOSITION | KANSAI PAINT CO LTD (JP) | 2010-07-28 | — | — | EP | disclosed |
| EP-2000489-A9 | CURABLE AQUEOUS COMPOSITION | Kansai Paint Co., Ltd. (JP) | 2009-03-11 | — | — | EP | disclosed |
| EP-2000489-A2 | CURABLE AQUEOUS COMPOSITION | Kansai Paint Co., Ltd. (JP) | 2008-12-10 | — | — | EP | disclosed |
| US-20080053835-A1 | Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition | KANSAI PAINT CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1798218-A1 | MONOMER COMPOUND, PROCESS FOR PRODUCING THE SAME, POLYMER THEREOF, AND WATER-BASED CURABLE COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
| WO-2003019383-A1 | CRYSTALLINE ALUMINOPHOSPHATE PRODUCTION PROCESS AND CRYSTALLINE ALUMINOPHOSPHATE | SHOWA DENKO KK (JP) | 2003-03-06 | — | — | WO | disclosed |
| EP-0519747-B1 | Cement admixture and defoaming agent | GRACE W R & CO (US) | 1996-09-04 | — | — | EP | disclosed |
| EP-0519747-A2 | Cement admixture and defoaming agent | W.R. Grace & Co.-Conn. (US) | 1992-12-23 | — | — | EP | disclosed |
| US-5156679-A | Water soluble alkylated alkanolamine salts | W. R. GRACE & CO.-CONN. (US) | 1992-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851390-B2 | Reaction of glycoladehyde | ADH1A, ADH1C, GRHPR | TSHR 3008/4885ALDH1A1 26/4885PKM 1907/4885 |
| US-20080053835-A1 | Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition | THEM6, PAM, WEE1 | TSHR 4460/4885ALDH1A1 741/4885PKM 1730/4885 |
| US-20210139410-A1 | REACTION OF GLYCOLADEHYDE | ADH1A, ADH1C, GRHPR | TSHR 3008/4885ALDH1A1 26/4885PKM 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.